Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Jerini and Baxter report update on nonintravenous hemophilia therapy program

May 23, 2006

New agents for treating thrombosis and related disorders reported in recent patents

May 18, 2006

Maxygen achieves milestone in Roche factor VIIa collaboration

May 12, 2006

Rac1 GTPase a novel antiplatelet target for the management of thrombosis

May 11, 2006

Plavix launched in Japan

May 10, 2006

New coagulation factor Xa inhibitors emerge from Bristol-Myers Squibb R&D

May 10, 2006

Heparins interfere with P-selectin binding and block metastasis

May 9, 2006

Novel antiatherothrombotic drug shows promise in preclinical studies

May 5, 2006

Oral direct thrombin inhibitor MPC-0920 begins phase I study

May 4, 2006

New treatment options reported for disorders associated with blood coagulation

May 3, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...